David Eldred‐Evans

IP26-20 TRANSITION ZONE SAMPLING: A SIMPLE STEP THAT PREVENTS ERRORS IN FOCAL THERAPY CANDIDATE SELECTION

James L. McIrvine, Alex Lloyd, Sarah Ashraf, Michael Monaghan et autres

Diagnostic accuracy of a ‘stage-gated’ approach for reporting prostate screening MRI: “Is less more?”

Natasha Thorley, Tom Parry, Giorgio Brembilla, Francesco Giganti et autres

OBJECTIVES: To evaluate whether a two-step, 'stage-gated' reporting approach could improve the positive predictive value (PPV) of biparametric (bp)MRI for prostate cancer (PCa) screening compared to conventional Likert/PI-RADS scoring. MATERIALS AND METHODS: This retrospective secondary analysis utilised data from IP1-PROSTAGRAM-a prospective, population-based …

gb, it (code pays fourni par la source)

A Novel ‘Stage-Gated’ Approach for Reporting Prostate Screening MRI: “Is Less More?”

Natasha Thorley, Giorgio Brembilla, Francesco Giganti, Tristan Barrett et autres

Motivation: Prostate MRI is a promising screening tool for prostate cancer, but it has a low positive predictive value (PPV), likely because assessment systems are not optimised for low disease prevalence. Goal(s): To evaluate whether a novel two-step, 'stage-gated' biparametric (bp)MRI reporting …

Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative Group

Sunny B. Nalavenkata, Emily Vertosick, Alberto Briganti, Hashim Uddin Ahmed et autres

us, it, gb, de, au, hk, ch, ca (code pays fourni par la source)

PD39-01 THE SUITABILITY OF HEMI-ABLATION FOR PATIENTS DIAGNOSED WITH LOCALISED PROSTATE CANCER FOLLOWING MULTIPARAMETRIC MRI TARGETED AND NON-TARGETED TRANSPERINEAL PROSTATE BIOPSY

Deepika Reddy, David Eldred‐Evans, Mathias H. Winkler, Taimur Tariq Shah et autres

You have accessJournal of UrologyProstate Cancer: Localized: Ablative Therapy II (PD39)1 May 2024PD39-01 THE SUITABILITY OF HEMI-ABLATION FOR PATIENTS DIAGNOSED WITH LOCALISED PROSTATE CANCER FOLLOWING MULTIPARAMETRIC MRI TARGETED AND NON-TARGETED TRANSPERINEAL PROSTATE BIOPSY Deepika Reddy, David Eldred-Evans, Mathias Winkler, Taimur Shah, and …

PD19-07 VARIATION IN THE POSITIVE PREDICTIVE VALUE OF PROSTATE MRI: DATA FROM THE PROSTATE BIOPSY COLLABORATIVE GROUP

Sunny B. Nalavenkata, Emily Vertosick, Alberto Briganti, Hashim Uddin Ahmed et autres

You have accessJournal of UrologyProstate Cancer: Detection & Screening II (PD19)1 May 2024PD19-07 VARIATION IN THE POSITIVE PREDICTIVE VALUE OF PROSTATE MRI: DATA FROM THE PROSTATE BIOPSY COLLABORATIVE GROUP Sunny Nalavenkata, Emily Vertosick, Alberto Briganti, Hashim Ahmed, David Eldred-Evans, Kathie Wong, Stephen …

Local anaesthetic transperineal prostate biopsy: What is the learning curve?

Nikhil Mayor, Aso Faeq Salih, M.S. Inder, Alexander Light et autres

Acceptability of magnetic resonance imaging for prostate cancer diagnosis with patients and GPs: a qualitative interview study

Samuel WD Merriel, Stephanie Archer, Alice S. Forster, David Eldred‐Evans et autres

BACKGROUND: Magnetic resonance imaging (MRI) of the prostate is a new, more accurate, non-invasive test for prostate cancer diagnosis. AIM: To understand the acceptability of MRI for patients and GPs for prostate cancer diagnosis. DESIGN AND SETTING: Qualitative study of men who …

gb, pt, ca (code pays fourni par la source)

PSA density reduces biopsy rates in a screening population: outcomes from the IP1-PROSTAGRAM study

Nikhil Mayor, David Eldred‐Evans, P. Burak, Martin John Connor et autres

Prostagram magnetic resonance imaging in a screening population: Prostate Imaging‐Reporting and Data System or Likert?

Nikhil Mayor, David Eldred‐Evans, Henry Tam, Heminder K. Sokhi et autres

OBJECTIVE: To compare biopsy recommendation rates and accuracy of the Prostate Imaging-Reporting and Data System, version 2 (PI-RADSv2) with the Likert scale for detection of clinically significant and insignificant prostate cancer in men screened within the Imperial Prostate 1 Prostate Cancer Screening …

gb (code pays fourni par la source)

An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

David Eldred‐Evans, Henry Tam, Heminder K. Sokhi, Anwar R. Padhani et autres

BACKGROUND: The use of prostate-specific antigen (PSA) testing to screen for prostate cancer has been fraught with under- and overdiagnosis. Short, noncontrast magnetic resonance imaging (MRI) might detect more grade group ≥2 cancers with similar rates of biopsy. OBJECTIVE: To evaluate strategies …

gb (code pays fourni par la source)

Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study

David Eldred‐Evans, Mathias H. Winkler, Natalia Klimowska‐Nassar, Paula Burak et autres

BACKGROUND: The IP1-PROSTAGRAM study showed that a short, non-contrast MRI detected more significant cancers with similar rates of biopsy compared to PSA. Herein, we compare the expected and perceived burden of PSA, MRI and ultrasound as screening tests. METHODS: IP1-PROSTAGRAM was a …

gb (code pays fourni par la source)